Latest Regulatory News


ECHA: BPC Concludes on Union Authorisations

In late June 2019 the BP Committee (BPC) adopted four opinions, including one on the non-approval of the active substance (DBNPA – PT4) on ED properties and three (2 x PT4; 1 x PT18) on Union Authorisation (UA).

DBNPA is not approved for product type 4 unless one of the following BPR derogations can be applied:

  1. The risk of exposure to the environment, human and animal health is proven to be negligible; or
  2. There is evidence that the active substance is essential to prevent or control a serious danger to the environment, human or animal health; or
  3. The non-approval is shown to have a negative impact on society compared to the risks arising from the use of the substance.

The positive opinion supporting UA for PT18 is one application concerning a biocidal product family based on permethrin and S-Methoprene.

The next BPC meeting will be held in October 2019.

 

Latest Regulatory News

Jul-2021

Chemicals and REACH > News

European Commission Roadmaps on the Revision of CLP (2021) & REACH (2022)

In May 2021, the EU Commission published two roadmaps (Inception Impact Assessments) on the revision of the CLP and the REACH Regulations in line with...

Read More

Jun-2021

News > Vet Medicine

UKs Veterinary Medicines Directorate updates guidance to GB manufacturers supplying the NI market

The 2021 Guidance update relates to manufacture and distribution of veterinary medicines and the rules of origin for veterinary medicines or Active Pharmaceutical Ingredients (API)...

Read More

Contact

LKC Switzerland Ltd
Hauptstrasse 10
P.O. Box 167
4414 Füllinsdorf
Switzerland

Phone: +41 (0) 61 906 8500
Fax: +41 (0) 61 906 8509
LKC@lkc-ltd.com

Information

Registration Number: CHE-113.597.134

Upcoming Events

2007-2021 © Copyright LKC Switzerland Ltd

Sign Up for Newsletter

x